MEMOTEXT and Metabolic Markets have entered into a strategic partnership, integrating MEMOTEXT's best-in-class patient adherence platform into the Metabolic Markets' client offerings.
"Patient compliance and adherence has long been one of the biggest challenges in chronic disease management. MEMOTEXT's unique, customized programs aimed at individualizing and increasing patient engagement, result in improved compliance and provide significant value to the healthcare system by reducing the overall impact and increased positive patient outcomes" stated Metabolic Markets partner Dr. Damon Tanton.
MEMOTEXT CEO Amos Adler commented, "Integrating Metabolic Markets clinical and health system expertise further enhances the delivery of MEMOTEXT’S adherence solution to patients, health care providers and payers. We look forward to expanding the utilization of MEMOTEXT’s platform throughout the health care continuum with the Metabolic Markets partnership."
Metabolic Markets will promote { MEMOTEXT’s patient compliance platform across its client base of manufacturers, managed care organizations and government health systems.
About MEMOTEXT
MEMOTEXT® integrates behavior modification, patient education and real-time patient support into the everyday lives of patients. This approach improves adherence using interactive multimedia assessment and telecommunications tools. www.memotext.com
About Metabolic Markets
Metabolic Markets is the first strategic sale/marketing/reimbursement consulting company to focus on the unique commercial challenges in diabetes, obesity and other metabolic disorders.
Metabolic Markets was founded by Aaron Davis and Dr. Damon Tanton under the belief that bringing commercial and clinical expertise together in a focused consultancy will deliver enhanced value to clients, improving access and increasing treatment modalities in the global healthcare crisis of diabetes and obesity. www.metabolicmarkets.com